BioLineRx (BLRX) Posts Q1 Loss of 1c/Share
BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.01), $0.05 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.01), $0.05 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.